Trial Profile
A Double Blind Randomized Controlled Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Sep 2023
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hypertriglyceridaemia
- Focus Biomarker; Therapeutic Use
- 03 Nov 2011 Planned End Date changed from 1 Dec 2010 to 1 Mar 2012 as reported by ClinicalTrials.gov.
- 03 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 12 Jun 2009 Planned end date changed from 1 Mar 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.